PHARMA-PACK
InactiveFinancials · financial year 2022, abbreviated format
2019 to 2022, 4 financial years 2019 to 2022, 4 financial years
The operating result has risen three years in a row; 2022 is 72% above 2021 and is the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
- 2022 Net result +76% on 2021. This financial year ran 21 months, the previous one 12.
| Line | 2019 | 2020 | 2021 | 2022 | Change |
|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €1.9m | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.06m | €0.04m | €0.04m | €0.04m | ▲ 5.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €0.1m | - |
| Other operating charges640/8 | - | - | - | €0.01m | - |
| Gross operating margin9900 | €1.0m | €1.7m | €1.9m | €3.3m | ▲ 75.1% |
| Operating profit (loss)9901 | -€0.2m | €0.6m | €0.7m | €1.2m | ▲ 72.0% |
| Financial income75/76B | - | - | - | €0.05m | - |
| Recurring financial income75 | €0.002m | €0.01m | €0.007m | €0.04m | ▲ 396% |
| Non-recurring financial income76B | - | - | - | €0.02m | - |
| Financial charges65/66B | - | - | - | €0.06m | - |
| Recurring financial charges65 | €0.02m | €0.03m | €0.03m | €0.05m | ▲ 81.4% |
| Non-recurring financial charges66B | - | - | - | €0.005m | - |
| Profit (loss) for the period before taxes9903 | -€0.2m | €0.6m | €0.7m | €1.2m | ▲ 76.2% |
| Income taxes67/77 | - | €0.1m | €0.2m | €0.3m | ▲ 76.8% |
| Profit (loss) for the period9904 | -€0.2m | €0.4m | €0.5m | €0.9m | ▲ 75.9% |
| Profit (loss) for the period to be appropriated9905 | -€0.2m | €0.4m | €0.5m | €0.9m | ▲ 75.9% |
| Line | 2019 | 2020 | 2021 | 2022 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €2.0m | €2.4m | €2.2m | €2.9m | ▲ 34.8% |
| Fixed assets21/28 | €0.5m | €0.4m | €0.4m | €0.05m | ▼ 88.4% |
| Intangible fixed assets21 | €0.04m | €0.03m | €0.03m | €0.03m | ▼ 11.5% |
| Tangible fixed assets22/27 | €0.5m | €0.4m | €0.4m | €0.02m | ▼ 94.9% |
| Plant, machinery and equipment23 | - | - | - | €0.01m | - |
| Furniture and vehicles24 | - | - | - | €0.007m | - |
| Financial fixed assets28 | €0.002m | €0.002m | €0.002m | €0.002m | = |
| Current assets29/58 | €1.5m | €1.9m | €1.7m | €2.9m | ▲ 63.9% |
| Stocks and contracts in progress3 | €0.6m | €0.6m | €0.9m | €0.9m | ▲ 8.7% |
| Stocks30/36 | - | - | - | €0.9m | - |
| Amounts receivable within one year40/41 | €0.8m | €1.2m | €0.6m | €0.8m | ▲ 19.6% |
| Trade receivables40 | - | - | - | €0.7m | - |
| Other amounts receivable41 | - | - | - | €0.06m | - |
| Cash at bank and in hand54/58 | €0.09m | €0.1m | €0.2m | €1.2m | ▲ 369% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €2.0m | €2.4m | €2.2m | €2.9m | ▲ 34.8% |
| Equity10/15 | €0.1m | €0.6m | €1.1m | €1.7m | ▲ 61.0% |
| Contributions10/11 | €0.02m | €0.02m | - | €0.01m | - |
| Reserves13 | €0.1m | €0.5m | €1.0m | €1.7m | ▲ 62.5% |
| Non-distributable reserves130/1 | - | - | - | €0.001m | - |
| Reserves not available under the articles1311 | - | - | - | €0.001m | - |
| Tax-exempt reserves132 | - | - | - | €0.006m | - |
| Distributable reserves133 | - | - | - | €1.7m | - |
| Amounts payable17/49 | €1.9m | €1.8m | €1.1m | €1.2m | ▲ 9.0% |
| Amounts payable after more than one year17 | €0.2m | €0.1m | €0.1m | - | - |
| Amounts payable within one year42/48 | €1.6m | €1.6m | €1.0m | €1.2m | ▲ 23.5% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.01m | - |
| Trade debts44 | €0.9m | €0.8m | €0.3m | €0.8m | ▲ 166% |
| Suppliers440/4 | - | - | - | €0.8m | - |
| Taxes, remuneration and social security45 | - | - | - | €0.4m | - |
| Taxes450/3 | - | - | - | €0.2m | - |
| Remuneration and social security454/9 | - | - | - | €0.1m | - |
| Other amounts payable47/48 | - | - | - | €0.003m | - |
| Line | 2019 | 2020 | 2021 | 2022 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€186,572 | €429,148 | €511,466 | €899,793 | ▲ 75.9% |
| + Depreciation and write-downs630 | €61,664 | €44,835 | €36,735 | €38,908 | ▲ 5.9% |
| Operating cash flow (approximation) | -€124,908 | €473,983 | €548,201 | €938,701 | ▲ 71.2% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €325,842 | - |
| Change in cash | - | €9,820 | €149,346 | €915,283 | ▲ 513% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 37 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2022 | abbreviated format | 12-07-2023 | 2023-00244915 |
| 31-03-2021 | abbreviated format | 03-11-2021 | 2021-76000480 |
| 31-03-2020 | abbreviated format | 24-11-2020 | 2020-71700296 |
| 31-03-2019 | abbreviated format | 31-10-2019 | 2019-72300503 |
| 31-03-2018 | abbreviated format | 31-10-2018 | 2018-71400504 |
| 31-12-2016 | abbreviated format | 17-07-2017 | 2017-32300484 |
| 31-12-2015 | abbreviated format | 18-08-2016 | 2016-43600039 |
| 31-12-2014 | abbreviated format | 31-08-2015 | 2015-54300301 |
| 31-12-2013 | abbreviated format | 24-07-2014 | 2014-33700582 |
| 31-12-2012 | abbreviated format | 28-08-2013 | 2013-49700108 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.